Please wait while your page loads ...
From Monday, October 21, 2019 until Monday, October 21, 2019
Posted by Blair DeSaw
This webinar will provide education on RT001, a compound designed to ameliorate the process of free radical lipid peroxidation. This destructive process in the mitochondrial membrane causes neural dysfunction - diminished function or cell death. Retrotope is planning a Phase II/Phase III clinical trial for RT001 in FA patients.
The webinar begins at 7pm EST and is planned to span one hour.
You can access the webinar through WebEx
628 791 460
Join by phone
+1-510-338-9438 USA Toll
Access code: 628 791 460